MARKET

RANI

RANI

Rani Therapeutics Holdings, Inc.
NASDAQ
0.8028
+0.0178
+2.27%
After Hours: 0.8299 +0.0271 +3.38% 18:20 08/12 EDT
OPEN
0.7741
PREV CLOSE
0.7850
HIGH
0.8238
LOW
0.7741
VOLUME
539.02K
TURNOVER
--
52 WEEK HIGH
3.870
52 WEEK LOW
0.4404
MARKET CAP
109.39M
P/E (TTM)
-1.9662
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RANI last week (0803-0807)?
Weekly Report · 2d ago
Rani Therapeutics appoints Michelle Gilson to board
TipRanks · 08/04 12:49
*Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Dow Jones · 08/04 12:00
Press Release: Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Dow Jones · 08/04 12:00
Weekly Report: what happened at RANI last week (0727-0731)?
Weekly Report · 08/03 10:27
Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)
TipRanks · 07/30 11:39
Weekly Report: what happened at RANI last week (0720-0724)?
Weekly Report · 07/27 10:32
Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up
TipRanks · 07/25 13:01
More
About RANI
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).

Webull offers Rani Therapeutics Holdings Inc stock information, including NASDAQ: RANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RANI stock methods without spending real money on the virtual paper trading platform.